Revenue (Tables)

3 Months Ended

Mar. 31, 2025

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregation of Revenue

The following table presents the approximate percentage of our net sales by market group:

	Three Months Ended March 31,
	2025	2024
Biologics	39 %	37 %
Generics	16 %	18 %
Pharma	26 %	25 %
Contract-Manufactured Products	19 %	20 %
	100 %	100 %

The following table presents the approximate percentage of our net sales by product category:

	Three Months Ended March 31,
	2025	2024
High-Value Product ("HVP") Components	45 %	47 %
High-Value Product ("HVP") Delivery Devices	14 %	11 %
Standard Packaging	22 %	22 %
Contract-Manufactured Products	19 %	20 %
	100 %	100 %

The following table presents the approximate percentage of our net sales by geographic location:

	Three Months Ended March 31,
	2025	2024
Americas	49 %	43 %
Europe, Middle East, Africa	44 %	48 %
Asia Pacific	7 %	9 %
	100 %	100 %

Schedule of Change in Contract with Customer, Asset and Liability

The following table summarizes our contract assets and liabilities:

	($ in millions)
Contract assets, December 31, 2024	$	23.3
Contract assets, March 31, 2025	25.8
Change in contract assets - increase (decrease)	$	2.5
Deferred income, December 31, 2024	$	(53.2)
Deferred income, March 31, 2025	(47.8)
Change in deferred income - decrease (increase)	$	5.4